510(k) K223705

EndoflipTM 300 by Covidien, LLC — Product Code FFX

K223705 is an FDA 510(k) premarket notification submitted by Covidien, LLC for the device "EndoflipTM 300". The FDA issued a decision of Substantially Equivalent on April 14, 2023. The device falls under product code FFX (System, Gastrointestinal Motility (Electrical)), a Class II device regulated under 21 CFR 876.1725. Covidien, LLC has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 14, 2023
Date Received
December 12, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Gastrointestinal Motility (Electrical)
Device Class
Class II
Regulation Number
876.1725
Review Panel
GU
Submission Type